How five patients ‘caught’ Alzheimer’s disease from cadaver-sourced hormones
The treatment was banned in the 1980s due to the increased risk of another neurodegenerative condition, CJD.
Five adults in the UK with early-onset Alzheimer’s disease all received contaminated growth hormones from deceased donors during childhood, which scientists are claiming as proof the condition is potentially transmissible.
In a world first, University College London researchers have implicated a long-banned therapy using human cadaveric pituitary-derived growth hormone (c-hGH) in a handful of Alzheimer’s disease cases.
